Atricure Stock In The News

ATRC Stock  USD 40.60  1.80  4.25%   
Our overall analysis of AtriCure's news coverage and content from conventional and social sources shows investors' bearish mood towards AtriCure. The specific impact of AtriCure news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of AtriCure's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using AtriCure headlines in addition to utilizing other, more conventional financial analysis modules. Check out AtriCure Backtesting and AtriCure Hype Analysis.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

AtriCure Today Top News and Investor Outlook

Yahoo News
Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025
https://finance.yahoo.com/news/20-bucks-7-low-priced-105000969.html
 Bullish
Yahoo News
AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug
https://finance.yahoo.com/news/atricure-atrc-declined-due-concerns-104007685.html
 Bullish
Yahoo News
Chief Legal Officer Karl Dahlquist Sells 8,231 Shares of AtriCure Inc (ATRC)
https://finance.yahoo.com/news/chief-legal-officer-karl-dahlquist-140105410.html
 Bullish
Yahoo News
AtriCure (ATRC) Fell on Competitor Action
https://finance.yahoo.com/news/atricure-atrc-fell-competitor-action-054731845.html
 Bullish
Yahoo News
AtriCure Full Year 2023 Earnings: EPS Beats Expectations
https://finance.yahoo.com/news/atricure-full-2023-earnings-eps-142505500.html
 Neutral
Yahoo News
AtriCure, Inc. (NASDAQ:ATRC) Q4 2023 Earnings Call Transcript
https://finance.yahoo.com/news/atricure-inc-nasdaq-atrc-q4-163024967.html
 Bullish
Yahoo News
Q4 2023 AtriCure Inc Earnings Call
https://finance.yahoo.com/news/q4-2023-atricure-inc-earnings-142420873.html
 Bullish
Yahoo News
Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings
https://finance.yahoo.com/news/heres-key-metrics-tell-us-000009571.html
 Bullish
Yahoo News
AtriCure (ATRC) Reports Q4 Loss, Tops Revenue Estimates
https://finance.yahoo.com/news/atricure-atrc-reports-q4-loss-221003923.html
 Bullish
Yahoo News
AtriCure Inc (ATRC) Reports Strong Revenue Growth in Q4 and Full Year 2023
https://finance.yahoo.com/news/atricure-inc-atrc-reports-strong-214402511.html
 Bullish

AtriCure Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide AtriCure and other traded companies coverage with news coverage. We help investors stay connected with AtriCure headlines for the 31st of January to make an informed investment decision based on correlating the impacts of news items on AtriCure Stock performance. Please note that trading solely based on the AtriCure hype is not for everyone as timely availability and quick action are needed to avoid losses.
AtriCure's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help AtriCure investors visualize upcoming and past events in order to time the market based on AtriCure noise-free hype analysis.
AtriCure stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the AtriCure earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about AtriCure that are available to investors today. That information is available publicly through AtriCure media outlets and privately through word of mouth or via AtriCure internal channels. However, regardless of the origin, that massive amount of AtriCure data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AtriCure news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AtriCure relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AtriCure's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AtriCure alpha.

AtriCure Largest EPS Surprises

Earnings surprises can significantly impact AtriCure's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2013-08-01
2013-06-30-0.1-0.090.0110 
2012-08-02
2012-06-30-0.07-0.08-0.0114 
2011-11-01
2011-09-30-0.08-0.070.0112 
2011-08-02
2011-06-30-0.05-0.06-0.0120 
2011-05-04
2011-03-31-0.07-0.08-0.0114 
2024-10-29
2024-09-30-0.19-0.170.0210 
View All Earnings Estimates

AtriCure Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to AtriCure Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
29th of January 2025
AtriCure Reaches New 1-Year High - Heres What Happened - MarketBeat
at news.google.com 
Gurufocus Stories at Macroaxis
15th of January 2025
AtriCure Stock Surges Over 5 percent Amid Market Activity
at gurufocus.com 
businesswire News
13th of January 2025
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Finan...
at businesswire.com 
Yahoo News
8th of January 2025
Hysteroscopy Instruments Market Research 2024-2028 2033 Featuring Major Players - Medtroni...
at finance.yahoo.com 
Simply Wall St News at Macroaxis
24th of December 2024
Is AtriCure Using Debt In A Risky Way
at simplywall.st 
Google News at Macroaxis
10th of December 2024
Fmr LLC Has 27.30 Million Stock Position in AtriCure, Inc. - MarketBeat
at news.google.com 
news
3rd of December 2024
PDT Partners LLC Invests 665,000 in AtriCure, Inc.
at thelincolnianonline.com 
Yahoo News
20th of November 2024
AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
at finance.yahoo.com 
news
7th of November 2024
Perkins Capital Management Inc. Sells 500 Shares of AtriCure, Inc.
at thelincolnianonline.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AtriCure in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AtriCure's short interest history, or implied volatility extrapolated from AtriCure options trading.
When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:
Check out AtriCure Backtesting and AtriCure Hype Analysis.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.83)
Revenue Per Share
9.564
Quarterly Revenue Growth
0.179
Return On Assets
(0.04)
Return On Equity
(0.08)
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.